Back to Search
Start Over
Crosstalk between hepatic stellate cells and surrounding cells in hepatic fibrosis.
- Source :
-
International Immunopharmacology . Oct2021, Vol. 99, pN.PAG-N.PAG. 1p. - Publication Year :
- 2021
-
Abstract
- • In this article, we briefly summarize the interaction between hepatic stellate cells and surrounding cells including hepatocytes, liver sinusoidal endothelial cells, cholangiocytes, platelets, and Immune cells. • Bidirectional regulation of HSCs by a variety of immune cells, including macrophages, is not only related to their phenotype, but also related to the interaction between immune cells. • Combination therapy of anti-inflammatory, inhibiting hepatocytes damage, inhibiting HSCs activation and immune regulation based on cellular communication between HSCs and surrounding cells may be an effective method for the treatment of hepatic fibrosis. Hepatic fibrosis represents as a dynamic pathological process characterized by the net accumulation of extracellular matrix in the progression of various chronic liver diseases, including viral hepatitis, alcoholic liver disease, and metabolic associated fatty liver disease (MAFLD). Activation of hepatic stellate cells (HSCs) is well-defined to play a central role in the initiation and progression of hepatic fibrosis. However, the activation of HSCs is affected by the complicated microenvironments in liver, which largely attributes to the communication between hepatocytes and multiple tissue-resident cells, including sinusoidal endothelial cells, bile duct epithelial cells, platelets, T cells, B cells, macrophages, natural killer cells, neutrophils, dendritic cells, in the direct or indirect mechanisms. Cellular crosstalk between HSCs and surrounding cells contributes to the activation of HSCs and the progression of hepatic fibrosis. Currently, accumulating evidence have proven the complexity and plasticity of HSCs activation, and further clarification of cellular communication between HSCs and surrounding cells will provide sufficient clue to the development of novel diagnostic methods and therapeutic strategies for hepatic fibrosis. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15675769
- Volume :
- 99
- Database :
- Academic Search Index
- Journal :
- International Immunopharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 152204638
- Full Text :
- https://doi.org/10.1016/j.intimp.2021.108051